Innova: Rapid Antigen Detection for SARS-CoV-2 by Lateral Flow Assay.

In R4HCR: R for Health Care Research

Rapid Antigen Detection for SARS-CoV-2 by Lateral Flow Assay.

Description

The number of false positives in negative samples in each evaluation stage of the Innova lateral flow device.

Usage

Innova

Format

A data frame with 8 observations on the following 3 variables.

phase

Evalution phase

fp

Number of false positives

total

Total number of tests conducted

Details

The Innova LFD was a first-generation Lateral Flow Device (LFD) for rapid point-of-care (POC) SARS-CoV-2 testing. Peto at al conducted a phased evaluation of available SARS-CoV-2 antigen LFDs from 15th August to December 2020 and reported the diagnostic performance of the Innova LFD.

References

Peto, T., Affron, D., Afrough, B., Agasu, A., Ainsworth, M., Allanson, A., Allen, K., Allen, C., Archer, L., Ashbridge, N. and Aurfan, I., 2021. COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing. EClinicalMedicine, 36.

Examples

require(meta)

data(Innova, package = "R4HCR")

# Meta-analysis of false-positive fraction
ma1 <- metaprop(event = fp,
n = total,
studlab = phase,
backtransf=TRUE,
data = Innova)

R4HCR documentation built on Sept. 30, 2024, 9:46 a.m.